ABVC - Company ID 0001173313
The table below shows ABVC BIOPHARMA, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $31.94K | $140.32K | $192.07K | $388.25K | $152.21K | $137.34K |
| Short-term investments | $62.42K | $62.19K | $65.17K | $65.21K | $65.05K | $70.81K |
| Receivables | - | - | - | - | - | $1.53K |
| Inventory | - | - | $11.46K | $11.46K | $11.46K | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $411.73K |
| $648.85K |
| $4.07M |
| $2.77M |
| $1.47M |
| $2.15M |
| Property, plant & equipment | $12.83M | $12.82M | $12.06M | $8.22M | $8.17M | $7.93M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $19.40M | $19.73M | $21.18M | $16.24M | $14.88M | $14.46M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $5.69M | $5.39M | $6.51M | $6.53M | $6.73M | $6.32M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $7.13M | $6.90M | $6.72M | $6.75M | $6.92M | $6.48M |
| Retained earnings | -$79.16M | -$78.42M | -$73.30M | -$72.05M | -$69.79M | -$70.55M |
| Total equity | $10.29M | $10.77M | $12.06M | $7.01M | $5.40M | $8.36M |